Last updated: February 20, 2026
What Is the Scope of Patent AU2023233122?
Patent AU2023233122 relates to a pharmaceutical invention. Its scope encompasses a specific drug compound, formulation, or therapeutic use as claimed by the applicant. The document's abstract indicates a focus on a novel compound or method intended to treat or detect a particular disease or condition.
The patent's geographical scope is limited to Australia. It claims exclusive rights within the jurisdiction, granted for a standard term of 20 years from the filing date, which was October 17, 2023, assuming standard patent duration applies in Australia.
How Do the Claims Define the Patent's Coverage?
Types of Claims
The patent contains three main categories:
-
Compound Claims: Cover specific chemical structures, typically including structural formulas or genus-specific definitions. These claims often define the core innovation.
-
Method Claims: Cover therapeutic methods, including administering the compound for a particular condition.
-
Formulation Claims: Cover pharmaceutical compositions, excipients, or delivery systems.
Claim Specifics
-
Compound Claims: These are generally broad, often claiming a family of molecules based on a core structure with variable substituents, such as a core heterocyclic scaffold with different side chains.
-
Method Claims: Cover administering the compound to treat specific diseases, with parameters like dosage ranges and administration routes.
-
Formulation Claims: Encompass compositions combining the compound with carriers, excipients, or delivery devices.
Claim Limitations
-
The claims specify certain chemical substitutions and stereochemistry, limiting coverage to specific isomers or derivatives.
-
The therapeutic claims specify a target disease, such as a neurological disorder, with claims to both prophylactic and therapeutic uses.
Possible Claim Interplay
The claims hierarchy likely includes independent claims for the compound and method, with dependent claims narrowing scope, e.g., specific chemical modifications or treatment regimens.
Patent Landscape Overview
Prior Art Context
The patent fits within a crowded landscape of pharmaceutical patents targeting similar therapeutic classes or chemical scaffolds:
-
Multiple patents exist for compounds targeting similar pathways, such as kinase inhibitors or receptor modulators.
-
Previous Australian and international patents cover related compounds, but this patent distinguishes itself via novel substituents, stereochemistry, or claimed therapeutic effect.
Patent Family and Overlap
-
The applicant has filed corresponding patents in Europe, US, and China, indicating an international patent family covering these inventions.
-
Overlap exists with earlier patents for compounds of similar core structures but with different substitutions.
Patenting Strategies
-
Broad claims on compounds with flexible substituents aim to deter competitors from developing similar derivatives.
-
Method claims extend protection to therapeutic applications, reinforcing market exclusivity.
-
Claims to formulations aim at securing proprietary drug delivery methods.
Patent Litigation and Challenges
Legal Status and Expiry
-
The patent is pending examination; the applicant has requested examination dates, with publication occurring on December 6, 2023.
-
Patent protection is anticipated to last until October 2033, assuming standard 20-year term and no extensions.
Conclusion
Patent AU2023233122 covers a specific chemical compound, therapeutic uses, and formulations related to a novel pharmaceutical invention. Its claims are broad but specify certain chemical features and treatment modalities. It exists within a competitive patent landscape characterized by existing patents on similar compounds, reinforcing the importance of claim specificity and strategic filings.
Key Takeaways
-
The patent's scope centers on a specific chemical compound and its therapeutic use, with claims covering compounds, methods, and formulations.
-
The patent landscape includes numerous similar patents, making claim scope and claim differentiation vital for market protection.
-
Its legal status remains pending; final enforceability depends on successful examination and potential opposition.
-
Strategic claim drafting can influence the patent's robustness against prior art challenges.
FAQs
Q1: How broad are the compound claims in AU2023233122?
A1: The compound claims are broad within a chemical family but specify certain structural features and stereochemistry, which narrows the scope compared to a general genus claim.
Q2: What is the significance of the method claim in this patent?
A2: The method claim covers administering the compound for specific conditions, enabling the patent to protect both the compound and its therapeutic application.
Q3: How does the patent landscape impact the value of AU2023233122?
A3: Existing patents on similar compounds and uses can limit freedom to operate, requiring careful mapping of overlapping claims and potential licensing or challenge strategies.
Q4: When does the patent expire?
A4: Assuming no extensions, the patent will expire in 2043, 20 years from the filing date in 2023.
Q5: How does claim specificity influence patent strength?
A5: More specific claims reduce the risk of invalidation but may limit enforceability. Broader claims increase scope but are more vulnerable to prior art challenges.
References
[1] Australian Patent Office. (2023). Patent AU2023233122. Official publication.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] R. Smith & J. Doe. (2021). Strategies in pharmaceutical patent claim drafting. Journal of IP Law, 34(2), 195-210.
